Thiamphenicol

This classification denotes a protein synthesis inhibitor and antibiotic with the molecular formula C12H15Cl2NO5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FLQ7571NPM, chemically known as (+-)-threo-2,2-dichloro-n-(beta-hydroxy-alpha-(hydroxymethyl)-p-(methylsulfonyl)phenethyl)acetamide but generally known as thiamphenicol, which bears US NIH Compound Identifier 5433. European Medicines Agency schedules Thiamphenicol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10970MIG. The term THIAMPHENICOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). World Health Organization schedules thiamphenicol in its Anatomical Therapeutic Chemical (ATC) Classification. THIAMPHENICOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule thiamphenicol under HS 29414000 and SITC 54139. As of Q4 2014, THIAMPHENICOL remains the US FDA Preferred Term for this commodity. Thiamphenicol bears US NLM identifiers UMLS ID C0039854 and NCI Concept Code C61969. SMILES: CS(=O)(=O)C1=CC=C(C=C1)C(C(CO)NC(=O)C(CL)CL)O.